Bearish flow noted in Cytokinetics with 1,040 puts trading, or 1.2x expected. Most active are Apr-24 70 puts and Apr-24 76 calls, with total volume in those strikes near 1,000 contracts. The Put/Call Ratio is 2.27, while ATM IV is up over 7 points on the day. Earnings are expected on May 8th.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CYTK:
- Cytokinetics Announces Three Late Breaking Clinical Trial Presentations Relating to SEQUOIA-HCM at the European Society of Cardiology Heart Failure 2024 Congress
- Cytokinetics Presents Additional 48-Week Data From FOREST-HCM, the Open Label Extension Clinical Study of Aficamten, at The American College of Cardiology 73ʳᵈ Annual Scientific Session
- Cytokinetics presents additional 48-week data from FOREST-HCM study
- Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Cytokinetics to Participate in the 23rd Annual Needham Virtual Healthcare Conference
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue